25-Year-Old Wall Street AI Guru Successfully Hedges? Put Options Holdings Decline
On June 10, market data showed that the put options held by Leopold Aschenbrenner's fund, Situational Awareness LP, commonly declined. Among them, the VanEck Semiconductor ETF (SMH) fell by 6.79%, NVIDIA (NVDA) dropped by 2.77%, Oracle (ORCL) decreased by 4.77%, Broadcom (AVGO) fell by 4.6%, AMD dropped by 7.9%, Micron (MU) declined by 6.9%, TSMC fell by 5% on trade.xyz, ASML dropped by 1.9%, and Intel (INTC) decreased by 6.99%. Previously reported by BlockBeats, Situational Awareness LP's Q1 13-F report submitted to the SEC indicated a significant increase in protection or bets against the decline of AI/semiconductor-related assets, particularly in NVIDIA, the VanEck Semiconductor ETF, Broadcom, AMD, TSMC, ASML, and Micron. The value of put options reported in Q1 was approximately $8.459 billion, accounting for about 61.9% of its Q1 13F reported value; while the put options for Q4 2025 were only about $8.91 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
Crypto prices
More
